Publication | Closed Access

Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)

Cardiovascular DiseaseAntihypertensive TherapyPharmacologyCardiologyVascular BiologyPharmacotherapyInternational Nifedipine TrialMedicineAtherosclerosisCoronary Artery DiseaseCalcium-channel Blocker Nifedipine